Article info
Letter
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
- Correspondence to Rachel S Simpson, Toronto Allergists, Toronto, ON M5G 1E2, Canada; rachel.simpson{at}queensu.ca
Citation
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
Publication history
- Received September 24, 2019
- Revised December 10, 2019
- Accepted December 11, 2019
- First published December 19, 2019.
Online issue publication
March 19, 2020
Article Versions
- Previous version (19 December 2019).
- Previous version (10 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.